Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.3M Buy
489,889
+24,020
+5% +$2.72M 6.98% 2
2026
Q1
$51.9M Buy
465,869
+84,636
+22% +$10M 5.8% 2
2025
Q4
$51.4M Buy
381,233
+89,413
+31% +$9.76M 5.87% 1
2025
Q3
$24.8M Buy
+291,820
New +$17.9M 3.72% 15

Other funds holding ABVX

First Turn Management's ABVX Position: Q2 2026 in Review

First Turn Management increased its Abivax (ABVX) stake by 5.2% in Q2 2026, buying an estimated $2.72M and bringing the position to 489,889 shares worth $65.3M. The position accounts for 6.98% of the portfolio, ranked #2.

First Turn Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • First Turn Management held 489,889 shares of Abivax worth $65.3M as of Q2 2026.
  • First Turn Management bought 24,020 Abivax shares in Q2 2026, an estimated $2.72M.
  • Abivax made up 6.98% of First Turn Management's portfolio in Q2 2026, its #2 holding.
  • First Turn Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.